Table 1.
Characteristics of coronary heart disease patients and their medication
| Ex-smokers (n =35) | Non-smokers (n =29) | Smokers (n =21) | |
|---|---|---|---|
| Sex (M/F; % female) | 33/2 (6%) | 16/13 (45%) | 16/5 (24%) |
| Age (year) | 64.6 ± 1.5 | 66.9 ± 1.9 | 63 ± 1.5 |
| BMI (kg·m−2) | 26.4 ± 1.5 | 27.1 ± 0.7 | 26.3 ± 0.7 |
| Multi-vessel disease (n; %) | 12 (34%) | 10 (34%) | 6 (29%) |
| Unstable angina (n; %) | 18 (51%) | 17 (59%) | 11 (52%) |
| Hypertension (n; %) | 23 (66%) | 21 (73%) | 11 (52%) |
| Dyslipidemia (n; %) | 26 (74%) | 19 (66%) | 13 (62%) |
| Diabetes (n; %) | 14 (40%) | 13 (45%) | 5 (24%) |
| Family history (n; %) | 7 (20%) | 10 (34%) | 9 (43%) |
| Nitrates (n; %) | 20 (57%) | 23 (80%) | 18 (86%) |
| Ca-antagonists (n; %) | 5 (14%) | 5 (17%) | 4 (19%) |
| ARBs (n; %) | 7 (20%) | 8 (27%) | 2 (10%) |
| ACE-inhibitors (n; %) | 15 (43%) | 15 (52%) | 9 (43%) |
| Beta-blockers (n; %) | 27 (77%) | 19 (66%) | 13 (62%) |
| Statins (n; %) | 23 (66%) | 16 (55%) | 12 (57%) |
| Anti-diabetics (n; %) | 14 (40%) | 10 (34%) | 5 (24%) |
| ASA/anti-platelet (n; %) | 35 (100%) | 29 (100%) | 21 (100%) |
Values are mean ± SEM.
BMI, body mass index; ARBs, angiotensin II receptor antagonists; ACE, angiotensin converting enzyme; ASA: aspirin.